Literature DB >> 9776841

In vitro activity of voriconazole against selected fungi.

M R McGinnis1, L Pasarell, D A Sutton, A W Fothergill, C R Cooper, M G Rinaldi.   

Abstract

Fifty-nine isolates consisting of 14 genera and 33 species of ascomycetes, basidiomycetes, and zygomycetes were tested against amphotericin B, fluconazole, itraconazole and voriconazole using an in vitro modified macrobroth dilution procedure based upon the NCCLS M27-A standard method for yeasts. The triazoles voriconazole and itraconazole had similar MIC values, except for Acremonium alabamensis, A. strictum, Fusarium oxysporum, F. solani and Wangiella dermatitidis, which had substantially lower voriconazole MIC values. Voriconazole MIC values were lower than those for itraconazole for the 17 species of Trichosporon tested. Fluconazole had high MIC values, often greater than 128 microg ml-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776841

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  16 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.

Authors:  Rama Falk; Dana G Wolf; Mervyn Shapiro; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

4.  In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.

Authors:  Valérie Letscher-Bru; France Campos; Jocelyn Waller; Raoul Randriamahazaka; Ermanno Candolfi; Raoul Herbrecht
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 7.  Curvularia keratitis.

Authors:  K R Wilhelmus; D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  2001

8.  Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.

Authors:  Giovanni Di Bonaventura; Arianna Pompilio; Carla Picciani; Manuela Iezzi; Domenico D'Antonio; Raffaele Piccolomini
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 9.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.

Authors:  William J Steinbach; Wiley A Schell; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 10.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.